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Background: There is much fragmentation and little consensus in the use of descriptors for the 
different disciplines that make up the pharmacy sector. Globalization, reprofessionalization and 
the influx of other disciplines means there is a requirement for a greater degree of standardization. 
This has not been well addressed in the pharmacy practice research and education literature.
Objectives: To identify and define the various subdisciplines of the pharmacy sector and 
integrate them into an internationally relevant conceptual model based on narrative synthesis 
of the literature.
Methods: A literature review was undertaken to understand the fragmentation in dialogue 
surrounding definitions relating to concepts and practices in the context of the pharmacy sec-
tor. From a synthesis of this literature, the need for this model was justified. Key assumptions 
of the model were identified, and an organic process of development took place with the three 
authors engaging in a process of sense-making to theorize the model.
Results: The model is “fit for purpose” across multiple countries and includes two components 
making up the umbrella term “pharmaceutical practice”. The first component is the four con-
ceptual dimensions, which outline the disciplines including social and administrative sciences, 
community pharmacy, clinical pharmacy and pharmaceutical sciences. The second component 
of the model describes the “acts of practice”: teaching, research and professional advocacy; 
service and academic enterprise.
Conclusions: This model aims to expose issues relating to defining pharmacy and its practice 
and to create dialogue. No model is perfect, but there are implications for what is posited in 
the areas of policy, education and practice and future research. The main point is the need for 
increased clarity, or at least beginning the discussion to increase the clarity of definition and 
consistency of meaning in-and-across the pharmacy sector locally, nationally and internationally.
Keywords: defining pharmacy, global standardization, conceptual model, normative practices
Introduction
The aim of this article is to identify and define the various subdisciplines of the pharmacy 
sector and integrate them into an internationally relevant conceptual model based on 
narrative synthesis of the literature. It is expected that significant dialogue will be derived 
from this article, and it is expected that it will provide a platform for moving forward in 
international pharmacy education. This is important because there is much fragmentation 
and little consensus in the use of descriptors for the different disciplines that make up 
the pharmaceutical sector. Globalization, reprofessionalization and the influx of other 
disciplines means there is a requirement for a greater degree of standardization. This 
has not been well addressed in the pharmacy practice research and education literature.
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Pharmacy education can be broadly divided into four 
areas: 1) pharmaceutics (sometimes labeled as pharmaceutical 
technology) and pharmacokinetics, 2) pharmaceutical chem-
istry, 3) pharmacology and 4) pharmacy practice includes 
clinical pharmacy, pharmacotherapy, social and administra-
tive sciences, and pharmaceutical care. These subparts of the 
fourth category are often aggregated in a disparate manner. 
The first three categories are closely aligned with the basic sci-
ences; the fourth category is inclusive of the human sciences. 
This fourth category has greater ambiguity, at least from the 
stance of definitions.1 Internationally, social and administra-
tive pharmacy, clinical pharmacy, pharmaceutical care and 
pharmacy practice are terms used to describe different aspects 
of pharmacy practice.1–7 However, these terms have a level 
of subjectivity and mean different things to different people.
There is an emergent literature on the field of social 
pharmacy8–15 and particularly in terms of education.16–22 
There is a literature that defines pharmaceutical care5,23–26 
with some focus on community pharmacy.27–30 Similarly, 
there is a dialogue on what constitutes clinical pharmacy 
and how this relates to pharmaceutical care,31–33 but there 
is no model which defines these concepts and draws them 
together as a whole.34–36 Even between the proponents of the 
closely related concepts of social pharmacy and pharmacy 
practice, there is a lack of consensus on the research agendas 
for each subdiscipline and a call for a systematic analysis 
of this and further dialog.1–4,6,7,32 33,37,38 Equally, translational 
research – that is taking bench to bedside (and the reverse) – 
is increasingly blurring the lines between what is considered 
“hard science” and what is deemed to be “soft practice”. In 
fact, “the sciences” fit under the umbrella of pharmaceutical 
practice, and we argue that these basic sciences should be 
part of a conceptual model of what it is to be “pharmacy”.
This article posits a model of pharmaceutical practice, 
which includes the professional practice activities of pharma-
cist clinicians. The term is distinct and has less controversial 
connotations than many others used interchangeably. The 
model also considers the broader roles undertaken by phar-
macists, such as involvement in the development of health 
policy. The model incorporates the influx of significant others 
(sociologists, psychologists, etc.) into the academic discipline 
of pharmacy, and the roles that these groupings have and 
the contribution of their work to pharmaceutical practice.37 
These roles are seen as a series of distinct disciplines within 
the conceptual model, but are at times blurred and have the 
potential to influence each other. The model outlines a con-
ceptual approach to redefining the labels attached to these 
various disciplines, but also the practices of pharmacy within 
each of these. Absolute consensus of a model like this is near 
impossible, with the overlap and conflation of the different 
disciplines being difficult to unpack. What is possible though 
is an increased level of international dialogue and a drive 
toward a greater level of consistency than is currently seen. 
This is a theoretical framework, a beginning!
Alignment between real-world practice and academic 
pharmacy is thought about and melded into the model. It 
is expected that this will be an evolving conceptual model 
informed by the history of research and international com-
mentary surrounding this topic.
The need for a global model
The need for a global conceptual model stems from the series 
of issues given below:
Reason 1 – different things to different 
people: multiple definitions
It is generally accepted that the disciplines of pharmaceutical 
science are founded on the basic sciences. Pharmaceutics, 
pharmaceutical chemistry, pharmacology and pharmaco-
kinetics are well-established subdisciplines of the pharma-
ceutical sciences. The same cannot be said for new evolving 
clinically oriented disciplines. Even in these relatively cir-
cumscribed areas of pharmacy theory and practice, there is a 
significant divergence in opinion of what constitutes each and 
how, where and why these terms overlap.1,3,4,32,33,39,40 Clinical 
pharmacy, pharmacy practice, community pharmacy, retail 
pharmacy, social pharmacy and translational research are all 
likely to mean different things to different people.
In the area of hospital pharmacy, the terms pharmacy 
practice, clinical pharmacy, pharmacotherapy and public 
sector pharmacy have all been used interchangeably. Descrip-
tions for community pharmacy have included pharmacy 
practice, retail pharmacy, community pharmacy, private sec-
tor pharmacy, private sector hospital pharmacy and clinical 
pharmacy practice in community pharmacies.1
Social and administrative pharmacy is used loosely to 
describe a collection of different interests, which outline 
the social aspects of pharmacy, sometimes labeled social 
pharmacy, other times administrative pharmacy but also 
pharmacy management. The broad discipline is founded on 
the principles of social science and organizational theory and 
has as a central interest in the beliefs, values and behaviors 
that people display in relation to medicine use and society at 
the individual and organizational levels.1–3,36,38,41–43 In some 
Commonwealth countries such as the UK, New Zealand 
and Australia, pharmacy practice seems to identify with 
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 community pharmacy with social pharmacy being considered 
a part of this. However, in the USA, social and administrative 
sciences has developed as a completely separate discipline 
and this also seems to be the case in parts of Asia.
Different from, but linked to, definitional difference is 
the idea that laws affecting practice will be different around 
the globe, and this means that it is more difficult to develop 
a consistent approach to interpreting practice-based defini-
tions. Although the model may be limited by this, there is an 
expectation that the context will determine how the model 
is applied in different countries and the overall assumptions 
and basic reasoning for the model apply globally – the need 
for further dialogue in this area certainly applies on an inter-
national scale! Furthermore, people can take from the model 
what they wish and apply it locally!
Reason 2 – the trend of clinical pharmacy 
and the Pharm D “tag”
Clinical pharmacy is an important discipline in the practice of 
pharmacy – it has a lot to offer and has played an important 
role in transformation of the pharmacy profession over the 
past two decades. Clinical pharmacy has been part of the 
“re-professionalization” agenda both within the hospital and 
community sectors.16,44–47 However, there are many definitions 
of clinical pharmacy, and the term “clinical pharmacy” has 
been understood differently across the globe. Some relate it 
to “patient care”, whereas others associate it more with the 
“managing appropriate use of medicines”.32
Amid these discussions in the developed world, the 
change has also greatly affected the pharmacy sector in 
developing countries, where establishing “clinical pharmacy” 
programs is considered a novel phenomenon. Under this 
influence, pharmaceutical care is popular jargon with the 
basic undergraduate pharmacy degrees having been changed 
to Doctor of Pharmacy (Pharm D) and the number of years 
of study simply extended in expectation of that.48 It would 
appear that pharmacy schools across Asia and within the 
Middle East are joining the “bandwagon” to promote clini-
cal pharmacy.1 These countries are re-adjusting their degree 
programs by introducing Pharm D degrees as entry level 
qualifications into pharmacy. In some countries, in particular, 
“clinical pharmacy” is evolving in a very interesting manner. 
For example, in Pakistan, there was no separate discipline of 
clinical pharmacy, which is being taught under the umbrella 
of pharmaceutics in some universities. However, recently a 
new pharmacy practice discipline has been established. Anec-
dotal evidence also suggests that tensions and rifts between 
pharmacy and pharmacology colleagues have occurred. 
Pharmacologists believe that they should teach clinical 
pharmacy programs. The pharmacologists’ rationale is that 
clinical pharmacy is close to their domain, pharmacology 
being the study drug action on the body.
In Western countries, clinical pharmacy is established 
only when a stable medicine system is in place in the hospitals 
and drug regulatory authorities are mandated and efficient. 
Most developing countries do not have this luxury and are 
struggling with the issues of quality, safety, efficacy and 
distribution of medicines.49 In this context, clinical phar-
macy is promoted as an isolated concept of practice and the 
underpinning philosophies are poorly understood and little 
has changed in terms of patient care.2
Reason 3 – passionate and motivated by 
our individual subdisciplines
Academics and practitioners see their discipline as central; 
yet, the literature is scarce when considering the pharmacy 
profession as a whole. Ahmed et al recognize these differ-
ences and suggest that a strong need exists to definitions 
relating to clinical pharmacy and pharmaceutical care.31 
These standard definitions must be agreed upon and dis-
seminated globally so that they are understood clearly (ie, 
clinical pharmacy and pharmaceutical care). This needs to be 
the case not only for pharmacists but also for other healthcare 
professionals and the wider disciplines, such as sociology and 
psychology. And, in this article, we take the work of Ahmed 
et al one step further and expand the need to develop a much 
broader model for pharmacists, other healthcare workers, 
government policy-makers and educators to take a sector-
wide approach.31
Reason 4 – what it is to be “pharmacy”
In our experience and through anecdote, a question that is 
commonly fielded from key stakeholders (patients, public 
and other health professionals) is “what is pharmacy about?”; 
“what is it you do as a pharmacy profession – do you just 
count pills?” How then do we explain to colleagues and 
external stakeholders what we actually do, what our potential 
is as a profession and what our teaching encapsulates and 
what our research is all about? How in the broadest sense 
do we explain what pharmacy aims to contribute to health 
outcomes and further, how it might do so? We have a lot of 
different terminologies to describe ourselves as the pharmacy 
profession. We might say we work in the area of pharmacy 
practice, clinical pharmacy or social and administrative sci-
ences. Importantly, medicines are not singularly the domain 
of pharmacists, and there is a need to help other nonpharmacy 
 
In
te
gr
at
ed
 P
ha
rm
ac
y 
Re
se
ar
ch
 a
nd
 P
ra
ct
ice
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
16
1.
11
2.
23
2.
10
2 
on
 2
5-
M
ay
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Integrated Pharmacy Research and Practice 2017:6submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
124
Scahill et al
disciplines to understand what constitutes the pharmacy 
sector by standardizing terminology. In this way, it will also 
be easier to fit with policy, or at least integrate with and be 
understood by policy-makers and clinician stakeholders.
Part of the confusion and fragmentation surrounding 
the pharmacy profession comes from the overlap in “what 
we do” and “how we do it” but also how we label “who we 
are” and “what we do”. For example, translational research 
is where basic and clinical sciences collide, cutting through 
boundaries between the research bench and patient bedside, 
empiric knowledge and soft practices. This creates an inher-
ent blurring in what is deemed to be pharmaceutical science 
and what is deemed to be “clinical practice”; at least, this 
is the case from an academic viewpoint. Pharmacy practice 
and social pharmacy are also loose and slippery concepts to 
define, less so pharmaceutical care. Again the boundaries 
are blurred, but there is a need to put a stake in the ground 
and define these concepts so that things are more concrete.
The pharmacy sector is evolving and with the influx of 
significant others (such as sociologists, psychologists, anthro-
pologists, historians, health economists, organizational and 
political scientists) into pharmacy academia and practice, 
the boundaries of the sector as a whole seem to have been 
extended and strengthened. For example, sociologists can 
conceptualize and operationalize research and practice that 
contribute significantly to introducing various behavioral 
models to the understanding of medicines use, thereby 
improving health outcomes. Research around pharmaceutical 
policy development and implementation, access to medicines 
and their use and pharmacoepidemiology are good examples 
of this type of work.
Summary of the need for a 
conceptual model
The definition of what constitutes “the pharmacy sector” and 
disciplines and practices thereof can be defined as broadly 
or as narrowly as one wishes. A narrow approach would 
feature the traditional elements of pharmacy, namely source 
and supply within a professional and regulated distribution 
model.44–47 Conversely, a broad conceptual stance would 
adopt elements from social and basic sciences as well.45 Either 
way a model is required, which redefines the pharmacy sector 
and the practices involved within the sector, both academic 
and professional. The model cuts through the current loose 
and interchangeable use of terminology and is founded on 
robust theoretical grounds. The authors’ own insights and 
experiences are also infused into the model, which has 
developed in an organic fashion.50
This conceptual model is founded on the notion of con-
sistency in definitions with respect to both the dimensions of 
the model and the model as a whole. The literature is scarce 
in describing the pharmacy sector “as a whole” and there are 
no “think piece” frameworks in this way. The main implica-
tion of the proposed model for theory is the call for clarity 
about the various parts of the pharmacy sector and how as a 
profession these dimensions may fit together.
Pharmaceutical practice: a 
conceptual model
Underpinned by the context previously outlined and with the 
need firmly established, we posit the term “pharmaceutical 
practice” and the associated conceptual model, which underpins 
this notion (Figure 1). The idea is that pharmaceutical practice 
encompasses everything, which is related to availability of medi-
cines, access and use at the individual and the population levels. 
This term encapsulates the research, development, formulation, 
distribution, access and clinical use of medicines. It incorporates 
the human capital required to deliver pharmacy services and the 
impact on end users of pharmaceutical products and services.
The dimensions: the glue making the whole
Dimensions of disciplines
Social and administrative sciences, community pharmacy, 
clinical pharmacy and pharmaceutical sciences are the dimen-
sions of our conceptual model, and a description of each of 
the dimensions is outlined below.
Social and administrative sciences
The field of social pharmacy developed initially within high-
income countries, including Scandinavia, Finland, the UK and 
the USA.45 More recently, there has been interest from aca-
demics in low- to middle-income countries and these groups 
have made significant contributions to this field.1,3,31 The 
International Social Pharmacy Workshop (ISPW) has been a 
foundation platform for the development of the research and 
practice networks within the discipline of social and admin-
istrative sciences. There are subtle differences between each 
workshop; however, the focus has been on research directed 
toward pharmaceutical policy, access to medicines, medi-
cine use and pharmacoepidemiology, pharmacoeconomics, 
organizational behavior and individual pharmacist practice.
There are pockets of academics particularly passionate 
about the field of social pharmacy. Norris highlighted the 
challenges that the discipline of social pharmacy faces.37 
Hassali et al have suggested social pharmacy as a field of 
study with a particular focus on the needs and challenges in 
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global  pharmacy education.3 However, we believe that social 
pharmacy is an important part of the broader construct of phar-
maceutical practice but is not the central umbrella concept – it 
is one of the four main dimensions. What are the other three?
Community pharmacy
Found within primary care, the practice of community phar-
macy is reasonably clear cut at least with respect to its dual 
nature, as retailer and as primary healthcare provider and its 
separation from the rest of the profession.51 There seems to 
be a number of “labels” applied to this aspect of pharmacy, 
including community pharmacy, retail pharmacy, private 
sector pharmacy and corporate pharmacy. Despite significant 
differences in service delivery models, we see community 
pharmacy as a collective form of practice centered on an 
organization embedded within a community. Although much 
activity is undertaken in community pharmacy, there is a 
scarcity of research at the organizational level.42
Clinical pharmacy
Clinical pharmacy is the term that is most commonly used in 
the context of hospital pharmacy, where the focus is on phar-
macotherapy and advanced subspecialties within this sector. 
The development of the clinical discipline is best reflected 
through the professionalization of hospital pharmacy in the 
USA.44 Although clinical pharmacy could be deemed to be 
carried out in the setting of community pharmacy, in the 
proposed model, there is a clear distinction between advanced 
clinical practice in the primary (clinical advisory pharma-
cists), secondary and tertiary care sectors (hospital clinical 
pharmacists), and clinical activities that are undertaken within 
the four walls of a community pharmacy. Pharmaceutical 
care involves a defined process and warrants consideration 
as it crosses boundaries by being able to be implemented in 
hospital pharmacy and also in the context of advanced clinical 
practice in the community pharmacy setting. Essentially, this 
is a clinical pharmacy service. The term “pharmacotherapy” 
also introduces a level of ambiguity as the label describes a 
process that could be owned by any health professional who 
is considered to have training in the area; nurse practitioners 
and clinical pharmacists are two examples.
Pharmaceutical sciences
As with the label of community pharmacy, pharmaceutical 
science is a relatively clear cut and well-defined aspect of 
the model. Ambiguity in this aspect of practice emerges 
only when one thinks about the potential of pharmaceuti-
cal sciences as a platform for translational research; bench 
research to bedside clinical use and bedside clinical issues 
influencing research activities at the bench! This is where 
crossover at multiple levels creates an inherent “blurriness”, 
which we believe the proposed model will help to manage. It 
Figure 1 A conceptual model for pharmaceutical practice.
The act of
practice
Social and
administrative
sciences
Community
pharmacy
Pharmaceutical
sciences
Clinical
pharmacy
Advocacy and
service Research
Conceptual
disciplines
Pharmaceutical practice
Teaching
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is also an area where universities are attempting to develop 
expertise and differentiate themselves from competitors, such 
as contract research organizations.
The act of practice
The act of practice can be thought of as those normative prac-
tices, the activities that are underpinned by what the culture 
of the specific discipline suggests is “normal”.52 Regardless 
of whether the practice is considered clinical pharmacy or 
community pharmacy, it will be underpinned by values and 
beliefs that drive normative behavior.52,53 These values and 
behaviors are expected to align with the concept of what it 
is to be “pharmacy” within the individual subdisciplines 
outlined in our model.
Teaching
Teaching will vary dependent on the models of pharmacy that 
are practiced in any one country. However, the “labels” for 
each of the subdimensions of our model should be used in 
the same manner to describe the normative practices under-
taken and the manner in which these practices are taught, 
regardless of country. That is, despite there being different 
needs in individual countries, the nomenclature/terminology 
being used should be broadly the same. The meaning of a 
definition in one country should be the same as in the next, 
despite slight variations in practice. The context may change 
but the meaning should not.
Research
Research underpins practice, and practice can also inform 
research questions. There is a potential research agenda that 
could be developed based on questions and issues raised by 
this model. This agenda is outlined as part of the implications 
of our model, found later in this modeling paper.
Service – advocacy, professional sector development and 
academic enterprise
Service and advocacy is an act of practice that does not 
appear as part of other models in the literature or dialogue 
about what constitutes a particular discipline. Essential to 
the model, this act of practice describes professional lead-
ership. The absence of this is a possible contributor to the 
lack of voice and recognition of pharmacy’s global role and 
the reason that pharmacy may be marginalized.54,55 As such, 
we believe this is an important and integral aspect of any 
pharmaceutical practice model as is the leadership, which 
underpins the model.55
The importance of local context in an international 
world
The individual dimensions of the pharmacy sector and 
their associated practices are influenced by local context. 
The proposed model takes this into consideration. There 
is a potential for tension between the viewpoints of those 
who call for curriculum development based wholly on local 
need analysis, alongside those who take the stance that “off-
the-shelf ” standardized degree programs from universities 
located in high-income countries is the optimal approach.56 
The proposed model allows for both, however, but under the 
proviso that there is standardization in the use of terminology.
International consistency: 
implications for policy, practice and 
research
The proposed conceptual model calls for a contemporary 
“rethink” about what constitutes the pharmacy sector in 
today’s terms.45 Historical review suggests that the pharmacy 
profession has changed over the past 100 years and consider-
ably over the past few decades. This has occurred mostly in 
the context of high-income countries.45 However, through 
migration and technology, the world is becoming an increas-
ingly small place. In general, there has been a lag in pharmacy 
education and practice change within low- to middle-income 
countries, which are now playing “catch up”, and there are 
significant implications of the proposed model, which takes 
a global perspective.57 This is not the case for all developing 
countries and there are examples such as Thailand with a 
long and strong tradition of social pharmacy and advocacy 
around medicines regulation, which many in high-income 
countries could learn from.
Implications for policy
The proposed model has implications for educational policy 
and practice. The first implication is that this model provides 
a level of consistency with respect to the different dimensions 
within the pharmacy sector and the associated practices that 
relate to these. Therefore, it should be clear to educational and 
medicine-related policy-makers what the different aspects of 
the pharmacy sector represent, regardless of country context. 
In this way, resultant policy is able to be more uniform and 
ideally could be shared within and across countries. At least 
this is a starting point, a platform by which to develop locally 
relevant policy. Furthermore, intercountry comparisons of 
policy interventions could be undertaken; there is a dearth 
of information in this area.
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Implications for education and practice
There is a level of globalization occurring within pharmacy 
education and in pharmacy practice circles, with the drift 
of pharmacists from low- to high-income countries on the 
increase.56 For countries that contribute to the “export mar-
ket” of pharmacists from low- to high-income countries, there 
will be a need for terminology and definitions that have the 
same broad meaning within and across these countries. This 
will also be necessary in those countries that are not con-
tributing to the pharmacist export market, but are publishing 
practice policy, guidelines or research.
The word “practice” is conceptualized as the “act of 
doing”52 and each of the four dimensions that constitute the 
pharmacy sector have an associated practice. With a concep-
tual model such as this, the act of practice can be better defined 
within each of the aspects that make up the pharmacy sector, 
they being community pharmacy, clinical pharmacy, social 
and administrative sciences and pharmaceutical science.
Implications for a future research agenda
The proposed model of what constitutes the pharmacy sector 
provides a platform for standardization of pharmacy concepts 
and ideologies and defines these in a clear manner. The aim is to 
significantly reduce the ambiguity associated with the labeling 
what we do in pharmacy; however, it is simply a starting point. 
There is a need to conduct an international survey (as part of a 
justification process) among a large number of pharmacy lead-
ers around the globe and others concerned, and then to present 
any amendments to this model. Facilitation of the survey could 
occur through the use of established international networks, 
such as ISPW, Pharmaceutical Care Network Europe or 
International Pharmaceutical Federation. The finalized model 
could then provide guidance for action with respect to policy 
development and implementation, practice and future research.
The proposed model was developed because of a per-
ceived need to reduce the fragmentation and confusion that 
lies within the various subdisciplines of the pharmacy sector 
and to provide a starting point for discussion, which might 
help to unify the sector. A significant and well-informed 
research agenda is able to be developed by thinking about the 
different aspects of the proposed model. The model could be 
used to explore gaps in policy, practice and research across 
the four aspects of the pharmacy sector within and across 
high-, low- and middle-income countries.
Conclusion
Through this article, we bring up a very relevant issue and 
suggest a solution by presenting a conceptual model, which 
is quite a challenge. There is a definite need for  clarifications 
and international standardizations of different aspects of 
pharmacy because of the various interpretations both within 
and between countries. To what extent practicing pharma-
cists, university professors, researchers and policy-makers 
agree with our interpretations and our division of conceptual 
 disciplines and facets is less relevant than the thought pro-
voked and the dialogue generated.
The article addresses the high level of fragmentation asso-
ciated with labels applied to the various disciplines within the 
pharmacy sector. This model takes due care in outlining high-
level reasons for why this model is required, which include the 
following: discipline labels meaning different things to differ-
ent people, the upward trend of clinical pharmacy, passionate 
and motivated drivers for subdisciplines and what it means to 
be part of the pharmacy sector. The model itself is fit for pur-
pose across multiple countries and includes two components of 
an umbrella term labeled “pharmaceutical practice”. The first 
component is the four conceptual dimensions, which outline 
the disciplines including social and administrative sciences, 
community pharmacy, clinical pharmacy and pharmaceutical 
sciences. The second component of the model describes the 
facets of the “act of practice”: teaching, research and profes-
sional advocacy. This overarching model is expected to provide 
a platform for further dialogue in the move toward consistency 
and rationalization of terminologies, which describe the global 
pharmacy sector. There are implications of this work for policy, 
education and practice, the main point being increased clarity, 
or at least beginning the discussion to increase the clarity of 
definition and consistency of meaning in and across the phar-
macy sector locally, nationally and internationally. Finally, a 
think piece of this nature throws up as many questions as it 
attempts to answer and it is expected that multicountry com-
parisons could be made based on such a model.
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